Drug regulation in the United States

International Journal of Technology Assessment in Health Care

Volumn 2, Issue 4, 1986, Pages 619-628

  Hutt, Peter Barton ^a  

^a Department of International Practice   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84974514632     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462300003457     Document Type: Article

References (6)

1. Flannery, E. J., & Hutt, P. B. Balancing competition and patent protection in the drug industry: the drug price competition and patent term restoration act of 1984, Food Drug Cosmetic Law Journal, 1985, 40, 269–309.
2. Hutt, P. B., Investigations and reports respecting FDA regulation of new drugs, Clinical Pharmacology and Therapeutics, 1983, 33, 537 (Part I) and 1983, 33, 674 (Part II).
3. Hutt, P. B., A legal framework for future decisions on transferring drugs from prescription to nonprescription status, Food Drug Cosmetic Law Journal, 1982, 37, 427–40.
4. Hutt, P. B., The importance of patent term restoration to pharmaceutical innovation. Health Affairs, 1982, 1, 6–33.
5. Hutt, P. B., The legal requirement that drugs be proved safe and effective before their use. In L. Lasagna (ed.), Controversies in therapeutics. Philadelphia: W. B. Saunders, 1980, 495–505.
6. Merrill, R. A., & Hutt, P. B. Food and drug law: cases and materials, St. Paul, MN: Foundation Press, 1980.